NCT03613064

Brief Summary

The investigators will conduct a feasibility study of an enhanced transitional care intervention, that will: 1) automate identification and risk-stratification of patients with CHF and IHD with social vulnerabilities; 2) incorporate a new standardized social vulnerabilities screening tool into clinical care; 3) enable electronic referrals to community resources; and 4) add novel community-based interventions to the existing medically-oriented transitional care intervention that is the standard of care at the study hospital (Parkland Hospital in Dallas, Texas) and other hospitals nationwide.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2023

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 2, 2018

Completed
4.8 years until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 5, 2025

Status Verified

August 1, 2025

Enrollment Period

1 year

First QC Date

May 31, 2018

Last Update Submit

August 28, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Reach of the intervention ('R' of the RE-AIM Implementation Science Framework)

    Proportion of individuals enrolled, of those who are eligible for the intervention

    Up to 12 months

  • Effectiveness of the intervention ('E' of the RE-AIM Implementation Science Framework) - Referrals

    Proportion of referrals to community-based service programs that are completed, of referrals that are sent. 'Completed' will be defined as individuals arriving in-person at a community-based service program after a referral is placed.

    Up to 12 months

  • Effectiveness of the intervention ('E' of the RE-AIM Implementation Science Framework) - Health Services Utilization

    Changes in acute health services use (composite of emergency department visits, hospitalizations) before and after the intervention using interrupted time series

    Up to 12 months

  • Effectiveness of the intervention ('E' of the RE-AIM Implementation Science Framework) - Satisfaction

    Patient satisfaction with the intervention program using brief verbal questionnaires

    Up to 12 months

  • Adoption of the intervention ('A' of the RE-AIM Implementation Science Framework)

    Number of community organizations active in referral and information exchange intervention

    Up to 12 months

  • Implementation of the intervention ('I' of the RE-AIM Implementation Science Framework)

    Acceptability, feasibility, and fidelity to intervention, ascertained through semi-structured interviews of research subjects, discharge planners, case managers, community program directors with thematic analysis of interview findings. We will ascertain perspectives on all three constructs during interviews and identify common themes across constructs to understand barriers and facilitators to implementation in aggregate

    Up to 12 months

Secondary Outcomes (1)

  • Readmission rate

    Up to 12 months

Study Arms (2)

Congestive Heart Failure (CHF)

EXPERIMENTAL

The CHF arm will include adults hospitalized with CHF who have been identified as being at high risk for readmission (in the top quintile of risk) by our readmission risk prediction algorithms, and who also have social vulnerabilities present. All subjects in the CHF arm will receive the Socially Enhanced Transitional Care Intervention.

Other: Socially Enhanced Transitional Care Intervention

Ischemic Heart Disease (IHD)

EXPERIMENTAL

The IHD arm will include adults hospitalized with IHD who have been identified as being at high risk for readmission (in the top quintile of risk) by our readmission risk prediction algorithms, and who also have social vulnerabilities present. All subjects in the IHD arm will receive the Socially Enhanced Transitional Care Intervention.

Other: Socially Enhanced Transitional Care Intervention

Interventions

Components: 1) Standardized social vulnerabilities assessment tool, to be developed and incorporated into admission workflows. 2) Electronic community service referrals to existing community resources (i.e. food banks, shelters, community rehab), via the Dallas IEP or other information technology platform, for material (food, housing) and psychosocial needs (mental health/drug treatment). 3) Community-based cardiovascular self-management interventions, to be developed and piloted in conjunction with #3 - e.g., customized 'heart healthy' food baskets for CHF/IHD; risk factor monitoring (i.e., weight and blood pressure measurement at food banks, shelters, churches, modeled on the barber shop hypertension intervention); and 'heart buddy' support groups for CHF and IHD at community sites.

Congestive Heart Failure (CHF)Ischemic Heart Disease (IHD)

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients hospitalized with CHF and IHD at high-risk for readmission

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart FailureMyocardial IschemiaCoronary Artery Disease

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular DiseasesCoronary DiseaseArteriosclerosisArterial Occlusive Diseases

Study Officials

  • Oanh K Nguyen, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2018

First Posted

August 2, 2018

Study Start

June 1, 2023

Primary Completion

June 1, 2024

Study Completion

December 1, 2024

Last Updated

September 5, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share